Check Athira Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$14.9M
EPS (TTM)
-6.2
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-56.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
1409900.00%
Compare market cap, revenue, PE, and other key metrics of Athira Pharma Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $14.9M | -97.79% | NA | 0.00% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Athira Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Athira Pharma Inc investment value today
Current value as on today
₹85,299
Returns
Returns from Athira Pharma Inc Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 12 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 12 analysts, 66.67% of analysts recommend a 'BUY' rating for Athira Pharma Inc. Average target price of $5
Get share price movements and forecasts by analysts on Athira Pharma Inc.
What analysts predicted
25.6%UPSIDE
Target Price
$5
Current Price
$3.72
Analyzed by
12 Analysts
Target
$5.00
Athira Pharma Inc target price $5, a slight upside of 25.6% compared to current price of $3.72. According to 12 analysts rating.
Search interest for Athira Pharma Inc Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:19% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 86.8%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 200.4%
Price Dip
In the last 3 years, ATHA stock has moved down by -88.9%
Organisation | Athira Pharma Inc |
Headquarters | 18706 North Creek Parkway, Bothell, WA, United States, 98011 |
Industry | Commercial Services |
CEO | Dr. Mark J. Litton M.B.A., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Robert Renninger | Senior VP of Finance & Accounting, Principal Financial Officer and Principal Accounting Officer |
Ms. Julie Rathbun | Head of Investor Relations |
Dr. Javier San Martin M.D. | Chief Medical Officer |
Dr. Mark J. Litton M.B.A., Ph.D. | President, CEO & Director |
Dr. Kevin Church Ph.D. | Chief Scientific Officer |
Mr. Mark F. Worthington J.D. | General Counsel, Chief Compliance Officer & Corporate Secretary |
Athira Pharma Inc share price today is $3.72 as on . Athira Pharma Inc share today touched a day high of $4.02 and a low of $3.71.
Athira Pharma Inc share touched a 52 week high of $8.26 on and a 52 week low of $2.2 on . Athira Pharma Inc stock price today i.e. is trending at $3.72,which is 54.99% down from its 52 week high and 69.44% up from its 52 week low.
Athira Pharma Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Athira Pharma Inc (ATHA) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Athira Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Athira Pharma Inc share’s latest price of $3.72 as on September 18, 2025 at 7:43 pm IST, you will get 2.6882 shares of Athira Pharma Inc. Learn more about
fractional shares .
Athira Pharma Inc stock has given -97.79% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?